Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Pharmacol Biochem Behav. 2015 Sep 26;138:104–110. doi: 10.1016/j.pbb.2015.09.018

Table 5.

Unstandardized estimates from main effects models predicting FTND and WISDM intermediate phenotypes from genetic variants


WISDM Subscales
FTND
Automaticity
Craving
Locus of
Control
Tolerance
β SE β SE β SE β SE β SE
Haplotype Block 1 [rs2282511 (TTC12), rs877138 (ANKK1)]
CA 0.49* 0.20 0.38* 0.01 0.22 0.16 0.23 0.15 0.22 0.15
AG −0.50 0.21 −0.34 0.16 −0.23 0.17 −0.23 0.16 −0.20 0.16
Haplotype Block 2 [rs17115439 (ANKK1) and rs4938013 (ANKK1)
TC 0.23 0.18 0.07 0.14 0.02 0.14 0.10 0.14 −0.03 0.14
TA −0.45 0.21 −0.34 0.16 −0.20 0.17 −0.22 0.16 −0.19 0.16
CC 0.10 0.18 0.17 0.13 0.12 0.14 0.07 0.13 0.16 0.13
Haplotype Block 3 [rs4938015 (ANKK1) and rs11604671 (ANKK1)]
TG −0.16 0.18 −0.19 0.13 −0.14 0.14 −0.06 0.13 −0.18 0.13
CG 0.09 0.19 0.17 0.15 0.14 0.15 0.01 0.14 0.20 0.14
Polymorphism Gene MA
rs618114 NCAM1 A −0.07 0.00 −0.16 0.18 0.03 0.19 0.04 0.18 −0.07 0.18
rs2303380 TTC12 G −0.30 0.01 −0.32 0.15 −0.16 0.16 −0.05 0.15 −0.15 0.15
rs1079597 DRD2 A −0.07 0.00 −0.39 0.19 −0.25 0.20 −0.13 0.19 −0.29 0.18
rs6277 DRD2 T 0.02 0.00 −0.12 0.22 −0.18 0.23 −0.12 0.22 −0.04 0.22
rs1800497 DRD2 T 0.30 0.01 −0.19 0.14 −0.18 0.15 −0.04 0.14 −0.23 0.14
rs4680 COMT A −0.02 0.20 −0.17 0.15 −0.13 0.16 −0.04 0.15 −0.07 0.15
rs1611115 DBH T 0.59 0.25 0.55* 0.19 0.52* 0.20 0.41 0.19 0.49* 0.19

Note. FTND=Fagerstrom Test of Nicotine Dependence; WISDM = Wisconsin Inventory of Smoking Motives; COMT = Catechol-O-methyltransferase gene; DBH = Dopamine beta-hydroxylase gene; ANKK1 = Ankyrin repeat and kinase domain containing 1 gene; DRD2 = Dopamine D2 receptor gene; NCAM1 = Neural cell adhesion molecule 1 gene; TTC12 = Tetratricopeptide Repeat Domain 12 gene. Block 1 = rs2282511 (TTC12), rs877138 (ANKK1); Block 2 = rs17115439 (ANKK1) and rs4938013 (ANKK1); Block 3 rs4938015 (ANKK1) and rs11604671 (ANKK1).

*

p < .01,

p < .05.